Switching Patients to Home-Based Subcutaneous Immunoglobulin: an Economic Evaluation of an Interprofessional Drug Therapy Management Program.
about
Optimizing the Bioavailability of Subcutaneously Administered Biotherapeutics Through Mechanochemical Drivers.Considerations for dosing immunoglobulin in obese patients.Latin American challenges with the diagnosis and treatment of primary immunodeficiency diseases.An evaluation of the budget impact of a new 20% subcutaneous immunoglobulin (Ig20Gly) for the management of primary immunodeficiency diseases in Switzerland.
P2860
Switching Patients to Home-Based Subcutaneous Immunoglobulin: an Economic Evaluation of an Interprofessional Drug Therapy Management Program.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Switching Patients to Home-Bas ...... ug Therapy Management Program.
@en
Switching Patients to Home-Bas ...... ug Therapy Management Program.
@nl
type
label
Switching Patients to Home-Bas ...... ug Therapy Management Program.
@en
Switching Patients to Home-Bas ...... ug Therapy Management Program.
@nl
prefLabel
Switching Patients to Home-Bas ...... ug Therapy Management Program.
@en
Switching Patients to Home-Bas ...... ug Therapy Management Program.
@nl
P2093
P2860
P1476
Switching Patients to Home-Bas ...... ug Therapy Management Program.
@en
P2093
Clemence Perraudin
Francois Spertini
Olivier Bugnon
P2860
P2888
P304
P356
10.1007/S10875-016-0288-Z
P577
2016-05-02T00:00:00Z